Continuous Glucose Monitoring (CGM) devices have been recently approved by FDA to be used in the type 1 diabetes (T1D) treatment non-adjunctively, i.e. without confirmatory fingerstick (SMBG) measurements (Edelman, JDST, 2017). Consequently, how to tune insulin bolus relying also on glucose rate of change (ROC), has become of particular interest. Our aim is to evaluate extensively in silico empirical literature methods proposed for such a scope
Recent advancements in CGM sensors (Continuous Glucose Monitoring) and insulin pumps considerably im...
Background and objective: In type 1 diabetes (T1D) research, in-silico clinical trials (ISCTs) notab...
"A self-tuning algorithm is presented for on-line insulin dosage adjustment in type 1 diabetic patie...
Background: Providing real-time magnitude and direction of glucose rate-of-change (ROC) via trend ar...
Patients with type 1 diabetes (T1D) require lifelong insulin therapy in order to maintain their bloo...
Type 1 Diabetes is a chronic metabolic disorder that is normally treated by subcutaneous administrat...
Introduction: In persons with type 1 diabetes (T1D) insulin dosing can be adjusted based on trend ar...
For individuals affected by Type 1 diabetes (T1D), a chronic disease in which the pancreas does not ...
Objective: This paper aims at proposing a new machine-learning based model to improve the calculatio...
In the daily management of type 1 diabetes (T1D), determining the correct insulin dose to be injecte...
The insulin to carbohydrate ratio (CR) is a parameter used by patients with type 1 diabetes (T1D) to...
Wearable continuous glucose monitoring (CGM) sensors are revolutionizing the treatment of type 1 dia...
Arguably, a minimally invasive system using subcutaneous (s.c.) continuous glucose monitoring (CGM) ...
Background and objective In type 1 diabetes (T1D) research, in-silico clinical trials (ISCTs) notab...
Background: In type 1 diabetes therapy, precise tuning of postprandial corrective insulin boluses (C...
Recent advancements in CGM sensors (Continuous Glucose Monitoring) and insulin pumps considerably im...
Background and objective: In type 1 diabetes (T1D) research, in-silico clinical trials (ISCTs) notab...
"A self-tuning algorithm is presented for on-line insulin dosage adjustment in type 1 diabetic patie...
Background: Providing real-time magnitude and direction of glucose rate-of-change (ROC) via trend ar...
Patients with type 1 diabetes (T1D) require lifelong insulin therapy in order to maintain their bloo...
Type 1 Diabetes is a chronic metabolic disorder that is normally treated by subcutaneous administrat...
Introduction: In persons with type 1 diabetes (T1D) insulin dosing can be adjusted based on trend ar...
For individuals affected by Type 1 diabetes (T1D), a chronic disease in which the pancreas does not ...
Objective: This paper aims at proposing a new machine-learning based model to improve the calculatio...
In the daily management of type 1 diabetes (T1D), determining the correct insulin dose to be injecte...
The insulin to carbohydrate ratio (CR) is a parameter used by patients with type 1 diabetes (T1D) to...
Wearable continuous glucose monitoring (CGM) sensors are revolutionizing the treatment of type 1 dia...
Arguably, a minimally invasive system using subcutaneous (s.c.) continuous glucose monitoring (CGM) ...
Background and objective In type 1 diabetes (T1D) research, in-silico clinical trials (ISCTs) notab...
Background: In type 1 diabetes therapy, precise tuning of postprandial corrective insulin boluses (C...
Recent advancements in CGM sensors (Continuous Glucose Monitoring) and insulin pumps considerably im...
Background and objective: In type 1 diabetes (T1D) research, in-silico clinical trials (ISCTs) notab...
"A self-tuning algorithm is presented for on-line insulin dosage adjustment in type 1 diabetic patie...